Atropine (sulfate monohydrate)

• UNSPSC Description:

  Atropine (Tropine tropate) sulfate monohydrate is a competitive muscarinic acetylcholine receptor (mAChR) antagonist with IC50 values of 0.39 and 0.71 nM for Human mAChR M4 and Chicken mAChR M4, respectively. Atropine sulfate monohydrate inhibits ACh-induced relaxations in human pulmonary veins. Atropine sulfate monohydrate can be used for research of anti-myopia and bradycardia[1][2][3][4].

• Target Antigen:

  mAChR

• Type:

  Natural Products

• Related Pathways:

  GPCR/G Protein;Neuronal Signaling

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Neurological Disease; Cardiovascular Disease; Cancer

• Assay Protocol:

  https://www.medchemexpress.com/Atropine-sulfate-monohydrate.html

• Purity:

  99.68

• Solubility:

  DMSO : 50 mg/mL (ultrasonic)|H2O : 33.33 mg/mL (ultrasonic)

• Smiles:

  O=[S](O)(O)=O.O=C(C(C1=CC=CC=C1)CO)O[C@H]2C[C@@H](CC3)N(C)[C@@H]3C2.O

• Molecular Weight:

  347.43

• References & Citations:

  [1]McBrien NA, et, al. How does atropine exert its anti-myopia effects? Ophthalmic Physiol Opt. 2013 May;33(3):373-8.|[2]Morhardt JE. Heart rates, breathing rates and the effects of atropine and acetylcholine on white-footed mice (Peromyscus sp.) during daily torpor. Comp Biochem Physiol. 1970 Mar 15;33(2):441-57.|[3]Carr BJ, et, al. Myopia-Inhibiting Concentrations of Muscarinic Receptor Antagonists Block Activation of Alpha2A-Adrenoceptors In Vitro. Invest Ophthalmol Vis Sci. 2018 Jun 1;59(7):2778-2791.|[4]Walch L, et, al. Evidence for a M(1) muscarinic receptor on the endothelium of human pulmonary veins. Br J Pharmacol. 2000 May;130(1):73-8. Cell Discov. 2023 Feb 7;9(1):16.|Neuron. 2022 Sep 14;S0896-6273(22)00796-6.|Arch Oral Biol. 2022: 105586.|Can J Physiol Pharmacol. 2020 Oct;98(10):725-732.|Cell Metab. 2022 Nov 11;S1550-4131(22)00490-9.|Cell Rep. 2022 Mar 8;38(10):110468.|Eur J Pharmacol. 2024 Sep 3:176954.|Food Chem. 30 November 2022, 133593.|Front Pharmacol. 2020 Jul 31;11:1038.|J Biosci. 2021;46:90.|J Ethnopharmacol. 2023 Sep 19;117192.|J Hazard Mater. 2023 Dec 14, 133248.|J Hazard Mater. 2024 Sep 5:479:135690.|Research Square Preprint. 2022 Mar.|Research Square Print. 2023 Feb 7.|Research Square Print. December 16th, 2022.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  4°C (Powder, sealed storage, away from moisture and light)

• Clinical Information:

  Launched

• CAS Number:

  5908-99-6